GPCM
ZYNE
Granite Point Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-43,000
| Closed | -$374K | – | 137 |
|
|
2018
Q1 | $374K | Sell |
43,000
-57,000
| -57% | -$496K | 0.04% | 75 |
|
|
2017
Q4 | $1.25M | Sell |
100,000
-100,000
| -50% | -$1.25M | 0.12% | 43 |
|
|
2017
Q3 | $1.67M | Buy |
200,000
+64,800
| +48% | +$542K | 0.35% | 34 |
|
|
2017
Q2 | $2.29M | Buy |
135,200
+36,200
| +37% | +$614K | 0.57% | 24 |
|
|
2017
Q1 | $1.99M | Buy |
+99,000
| New | +$1.99M | 0.59% | 20 |
|